ALX Oncology Holdings Inc (ALXO)

1.32 +0.03 (+2.33%) USD  |  NASDAQ  |  Nov 22, 10:00
More

ALX Oncology Holdings Return on Net Operating Assets

Return on Net Operating Assets Chart

View Return on Net Operating Assets for ALXO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Return on Net Operating Assets Data

View and export this data back to 2020. Upgrade now.
Date Value
June 30, 2020 --

Return on Net Operating Assets Range, Past 5 Years

Upgrade
Minimum
Jun 2020
Upgrade
Maximum
Jun 2020
Upgrade
Average
Upgrade
Median
Jun 2020

Return on Net Operating Assets Benchmarks

Biomarin Pharmaceutical Inc Upgrade
Neurocrine Biosciences Inc Upgrade
Eton Pharmaceuticals Inc Upgrade
Verve Therapeutics Inc Upgrade
Immuneering Corp --